Skip to content

The effect of the aerobic exercise associated to the upper extremity therapy in individuals after stroke

The effect of the aerobic exercise associated to the constraint-induced movement therapy in chronic hemiparetic individuals: a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-83pwm3
Enrollment
Unknown
Registered
2018-05-07
Start date
2018-05-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hemiparetic individuals post Stroke

Interventions

62 Individuals with chronic hemiparesis will be randomized into two groups: AE + mCIMT(31) and Control + CIMTm (31). The aerobic exercise and the stretching will be performed during 30 min, after 10
Other
G11.427.410.698.277

Sponsors

Universidade Federal de São Carlos
Lead Sponsor
Universidade Federal de São Carlos
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Chronic Hemiparetic individuals (more than 6 months) what the vascular accident involved the same hemisphere with lesions restricted to the middle and anterior vascular, report of the imaging test; 18 and 80 years; present a minimum active movement of 45° of shoulder flexion and abduction, 20° of elbow extension, 10° of wrist extension, 10° of abduction or extension of the thumb, and 10° extension in at least two fingers (metacarpophalangeal and interphalangeal joints) and thumb; present asymmetry in the use of the upper limbs with score 2.5 in the Motor Activity Log (MAL) Quantity Scale; ability to remain in a seated position without support for the trunk and/or of the arms for one minute

Exclusion criteria

Exclusion criteria: Individuals with cognitive deficits; smokers; alcohol; users of illicit drugs; with structural abnormalities in the cardiovascular and respiratory systems, uncorrected auditory and visual deficits, abnormalities on the electrocardiogram such as ischemic changes, arrhythmias, conduction disorders at rest and/or during the clinical exercise test; diseases or osteomiarticular alterations that affect the data collection or generate pain during the activities; obese (Body Mass Index more than 28 kg/ m2); diabetes mellitus and uncontrolled hypertension; comprehension aphasia; apraxia; stroke bilateral or acute or subacute stroke (less than 6 months) or transient vascular accident and other the central and peripheral nervous system diseases; who are participating in other experimental or rehabilitation studies; who have had botulinum toxin application in the last three months prior to evaluation will be not included

Design outcomes

Primary

MeasureTime frame
Improvement, immediately after of treatment, of motor dexterity, wich will be kept after 30 and 90 days after of intervention (retention) assessment by Nine-Hole Peg Test;Increase, immediately after of treatment, of the use of upper extremity more affected, wich will be kept after 30 and 90 days after of intervention (retention) assessment by Motor Activity Log;Increased, immediately after of treatment, in performance sensoriomotor durant the functionais activity, as drink, brush the hair and pick up a coin and put in a pot, wich will be kept after 30 and 90 days after of intervention (retention) assessment by kinematic

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactThiago Russo

Universidade Federal de São Carlos

thiagoluisrusso@gmail.com5501633519578

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 2, 2026